Cadrenal Therapeutics, Inc. CVKD
1.15
(0.05)
(4.17%)
as of 25 Sep
- Market cap
- $4.3M
- P/E
- 0.0×
Follow CVKD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
2.72 | 3.77 | 10.27 | 0.55 |
Net Debt/EBITDA |
0.30 | 0.91 | 1.10 | (0.20) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 71.10% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.10) |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.95 | 0.69 | 0.42 | 0.18 |
Capex/Depreciation |
(0.74) | (3.42) | (0.21) | (0.03) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (260.11%) | (140.78%) | (780.60%) | 0.00% | |
| (183.21%) | (114.27%) | (179.77%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(483.72%) | (143.25%) | (108.99%) | 1,108.15% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(6.32) | (6.04) | (3.93) | (2.29) |
Cash per Share |
2.01 | 8.21 | 9.34 | 0.06 |
Shareholders Equity per Share |
1.37 | 6.10 | 8.55 | (10.55) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.37 | 6.10 | 8.55 | (10.55) |
Free Cash Flow |
(12.61) | (7.36) | (3.53) | (1.21) |
Working Capital |
2.73 | 7.43 | 7.67 | (0.61) |
Capital Expenditures |
(0.01) | (0.01) | 0.00 | 0.00 |
Net Current Asset Value |
2.73 | 7.43 | 7.67 | (5.60) |
| Other line items | ||||
Quick Ratio |
2.53 | 3.75 | 10.21 | 0.02 |
Depreciation/Fixed assets |
1.33 | 0.28 | 6.74 | 68.20 |
Cash ROIC |
(186.87%) | (42.19%) | (21.95%) | 24.28% |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(6.32) | (6.03) | (3.92) | (2.29) |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 |
Average Receivables |
0.02 | 0.04 | — | — |
Average Payables |
1.08 | 0.83 | 0.29 | — |
Average Assets |
7.23 | 9.32 | 4.65 | — |
Average Common Equity |
5.09 | 7.57 | 1.07 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates